174 related articles for article (PubMed ID: 19429859)
21. The effects of epidermal growth factor receptor activation and attenuation of the TGFbeta pathway in an orthotopic model of colon cancer.
Ongchin M; Sharratt E; Dominguez I; Simms N; Wang J; Cheney R; LeVea C; Brattain M; Rajput A
J Surg Res; 2009 Oct; 156(2):250-6. PubMed ID: 19524264
[TBL] [Abstract][Full Text] [Related]
22. Inflammation and cancer: a failure of resolution?
Lawrence T
Trends Pharmacol Sci; 2007 Apr; 28(4):162-5. PubMed ID: 17331592
[TBL] [Abstract][Full Text] [Related]
23. Recent progress in animal modeling of immune inflammatory processes in schizophrenia: implication of specific cytokines.
Nawa H; Takei N
Neurosci Res; 2006 Sep; 56(1):2-13. PubMed ID: 16837094
[TBL] [Abstract][Full Text] [Related]
24. Genetic and epigenetic control of molecular alterations in hepatocellular carcinoma.
Feo F; Frau M; Tomasi ML; Brozzetti S; Pascale RM
Exp Biol Med (Maywood); 2009 Jul; 234(7):726-36. PubMed ID: 19429855
[TBL] [Abstract][Full Text] [Related]
25. Tumor necrosis factor-alpha and interleukin-1 antagonists alleviate inflammatory skin changes associated with epidermal growth factor receptor antibody therapy in mice.
Surguladze D; Deevi D; Claros N; Corcoran E; Wang S; Plym MJ; Wu Y; Doody J; Mauro DJ; Witte L; Busam KJ; Pytowski B; Rodeck U; Tonra JR
Cancer Res; 2009 Jul; 69(14):5643-7. PubMed ID: 19584274
[TBL] [Abstract][Full Text] [Related]
26. Comparative analysis of hepatocellular carcinoma in men and dogs.
Grabarević Z; Corić M; Seiwerth S; Dzaja P; Artuković B; Kurilj AG; Beck A; Hohsteter M; Sostarić-Zuckermann IC; Brcić L; Hrstić I
Coll Antropol; 2009 Sep; 33(3):811-4. PubMed ID: 19860108
[TBL] [Abstract][Full Text] [Related]
27. Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformation.
Talavera A; Friemann R; Gómez-Puerta S; Martinez-Fleites C; Garrido G; Rabasa A; López-Requena A; Pupo A; Johansen RF; Sánchez O; Krengel U; Moreno E
Cancer Res; 2009 Jul; 69(14):5851-9. PubMed ID: 19584289
[TBL] [Abstract][Full Text] [Related]
28. Molecular pathways: the complex roles of inflammation pathways in the development and treatment of liver cancer.
Nikolaou K; Sarris M; Talianidis I
Clin Cancer Res; 2013 Jun; 19(11):2810-6. PubMed ID: 23549874
[TBL] [Abstract][Full Text] [Related]
29. How much is too much? Interleukin-6 and its signalling in atherosclerosis.
Schuett H; Luchtefeld M; Grothusen C; Grote K; Schieffer B
Thromb Haemost; 2009 Aug; 102(2):215-22. PubMed ID: 19652871
[TBL] [Abstract][Full Text] [Related]
30. Role of alcohol in liver carcinogenesis.
McKillop IH; Schrum LW
Semin Liver Dis; 2009 May; 29(2):222-32. PubMed ID: 19387921
[TBL] [Abstract][Full Text] [Related]
31. Prostate inflammation and its potential impact on prostate cancer: a current review.
Haverkamp J; Charbonneau B; Ratliff TL
J Cell Biochem; 2008 Apr; 103(5):1344-53. PubMed ID: 17955503
[TBL] [Abstract][Full Text] [Related]
32. Prevention of hepatocellular carcinoma in nonviral-related liver diseases.
Fan JG; Farrell GC;
J Gastroenterol Hepatol; 2009 May; 24(5):712-9. PubMed ID: 19646014
[TBL] [Abstract][Full Text] [Related]
33. Pathway sensitivity analysis for detecting pro-proliferation activities of oncogenes and tumor suppressors of epidermal growth factor receptor-extracellular signal-regulated protein kinase pathway at altered protein levels.
Li H; Ung CY; Ma XH; Liu XH; Li BW; Low BC; Chen YZ
Cancer; 2009 Sep; 115(18):4246-63. PubMed ID: 19551902
[TBL] [Abstract][Full Text] [Related]
34. Occupational exposure to vinyl chloride and risk of hepatocellular carcinoma.
Dragani TA; Zocchetti C
Cancer Causes Control; 2008 Dec; 19(10):1193-200. PubMed ID: 18560983
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
36. B cell receptor and BAFF receptor signaling regulation of B cell homeostasis.
Khan WN
J Immunol; 2009 Sep; 183(6):3561-7. PubMed ID: 19726767
[TBL] [Abstract][Full Text] [Related]
37. The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis.
Berasain C; Avila MA
J Gastroenterol; 2014 Jan; 49(1):9-23. PubMed ID: 24318021
[TBL] [Abstract][Full Text] [Related]
38. Pathways connecting inflammation and cancer.
Allavena P; Garlanda C; Borrello MG; Sica A; Mantovani A
Curr Opin Genet Dev; 2008 Feb; 18(1):3-10. PubMed ID: 18325755
[TBL] [Abstract][Full Text] [Related]
39. Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities.
Modjtahedi H; Essapen S
Anticancer Drugs; 2009 Nov; 20(10):851-5. PubMed ID: 19826350
[TBL] [Abstract][Full Text] [Related]
40. Phosphoproteomics, oncogenic signaling and cancer research.
Chong PK; Lee H; Kong JW; Loh MC; Wong CH; Lim YP
Proteomics; 2008 Nov; 8(21):4370-82. PubMed ID: 18814326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
